ATE108996T1 - Verfahren zur herstellung eines pharmazeutischen granulats. - Google Patents

Verfahren zur herstellung eines pharmazeutischen granulats.

Info

Publication number
ATE108996T1
ATE108996T1 AT89200430T AT89200430T ATE108996T1 AT E108996 T1 ATE108996 T1 AT E108996T1 AT 89200430 T AT89200430 T AT 89200430T AT 89200430 T AT89200430 T AT 89200430T AT E108996 T1 ATE108996 T1 AT E108996T1
Authority
AT
Austria
Prior art keywords
production
granulate
wet
pharmaceutical granule
microcrystalline
Prior art date
Application number
AT89200430T
Other languages
English (en)
Inventor
Margaretha Olthoff
Bernardus Leonardus Dijkgraaf
Piet Johannes Akkerboom
Original Assignee
Brocades Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brocades Pharma Bv filed Critical Brocades Pharma Bv
Application granted granted Critical
Publication of ATE108996T1 publication Critical patent/ATE108996T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89200430T 1988-02-25 1989-02-20 Verfahren zur herstellung eines pharmazeutischen granulats. ATE108996T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88200346 1988-02-25

Publications (1)

Publication Number Publication Date
ATE108996T1 true ATE108996T1 (de) 1994-08-15

Family

ID=8199757

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89200430T ATE108996T1 (de) 1988-02-25 1989-02-20 Verfahren zur herstellung eines pharmazeutischen granulats.

Country Status (17)

Country Link
US (1) US5085869A (de)
EP (1) EP0330284B1 (de)
JP (1) JP2939262B2 (de)
KR (1) KR0135289B1 (de)
CN (1) CN1048395C (de)
AT (1) ATE108996T1 (de)
AU (1) AU611999B2 (de)
CA (1) CA1338553C (de)
DE (1) DE68916983T2 (de)
DK (1) DK175306B1 (de)
ES (1) ES2060737T3 (de)
FI (1) FI100219B (de)
IE (1) IE69366B1 (de)
IL (1) IL89378A (de)
NO (1) NO178485C (de)
NZ (1) NZ228122A (de)
PT (1) PT89823B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE69331839T2 (de) * 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
ATE160696T1 (de) * 1992-03-11 1997-12-15 Asta Medica Ag Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen
JP2964195B2 (ja) * 1992-04-28 1999-10-18 エスエス製薬株式会社 ピロキシカム錠及びその製造法
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
EA003736B1 (ru) * 1995-02-08 2003-08-28 Яманучи Юроп Б.В. Лекарственная форма для перорального введения, содержащая бета-лактамный антибиотик
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
EP0912169A2 (de) * 1996-07-16 1999-05-06 Gist-Brocades B.V. Organische lösungsmittelfreie beta-lactam enthaltende granulate
SI0948318T1 (en) * 1996-08-14 2004-08-31 Yamanouchi Europe B.V. Granulates comprising a water soluble compound and cellulose
WO1998036737A1 (en) * 1997-02-25 1998-08-27 The Procter & Gamble Company Wet granulating method
US5785995A (en) * 1997-04-11 1998-07-28 Upsher-Smith Laboratories, Inc. Pharmaceutical tablet of amiodarone salt
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
WO1999018965A1 (en) * 1997-10-10 1999-04-22 Yamanouchi Europe B.V. Oral compositions containing a cephalosporin antibiotic
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
CA2351357A1 (en) * 1998-12-23 2000-07-06 Novartis Ag Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors
EA003052B1 (ru) 1999-07-27 2002-12-26 Балканфарма Холдинг АД Антиаритмическое лекарственное средство
US20010053791A1 (en) * 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
EP1368003A4 (de) * 2001-02-05 2004-05-12 Scherer Technologies Inc R P Verfahren und zusammensetzungen zur verringerung des geschmacks von pharmazeutisch wirksamen mitteln
EP1469829B1 (de) * 2002-02-01 2016-01-27 Bend Research, Inc Rasch-freisetzende dosisformen enthaltend feststoffdispersionen
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
FR2991179B1 (fr) * 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes
WO2018011672A1 (en) * 2016-07-13 2018-01-18 Gangwal Chemicals Private Limited Process for directly compressible co-processed excipient for modified release application

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5438167B2 (de) * 1974-04-27 1979-11-19
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2058565B (en) * 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
NZ199931A (en) * 1981-03-13 1985-02-28 Lilly Co Eli Method for formulating medicated animal feed premix comprising a synthetic drug
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS6097919A (ja) * 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) * 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
EP0205336B1 (de) * 1985-06-11 1991-09-11 Teijin Limited Oral-Arzneizubereitung mit Retardwirkung
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds

Also Published As

Publication number Publication date
FI100219B (fi) 1997-10-31
FI890884A0 (fi) 1989-02-24
IE890545L (en) 1989-08-25
PT89823B (pt) 1994-04-29
NZ228122A (en) 1991-04-26
EP0330284B1 (de) 1994-07-27
IL89378A (en) 1993-01-31
DK86389A (da) 1989-08-26
CN1048395C (zh) 2000-01-19
NO178485C (no) 1996-04-10
NO890789D0 (no) 1989-02-24
KR0135289B1 (ko) 1998-04-23
KR900012603A (ko) 1990-09-01
NO890789L (no) 1989-08-28
EP0330284A3 (en) 1990-11-07
IL89378A0 (en) 1989-09-10
CN1035433A (zh) 1989-09-13
PT89823A (pt) 1989-10-04
JPH023606A (ja) 1990-01-09
JP2939262B2 (ja) 1999-08-25
DK86389D0 (da) 1989-02-24
NO178485B (no) 1996-01-02
CA1338553C (en) 1996-08-27
DK175306B1 (da) 2004-08-16
IE69366B1 (en) 1996-09-04
AU611999B2 (en) 1991-06-27
FI890884A (fi) 1989-08-26
EP0330284A2 (de) 1989-08-30
AU3015889A (en) 1989-08-31
US5085869A (en) 1992-02-04
ES2060737T3 (es) 1994-12-01
DE68916983T2 (de) 1995-01-19
DE68916983D1 (de) 1994-09-01

Similar Documents

Publication Publication Date Title
ATE108996T1 (de) Verfahren zur herstellung eines pharmazeutischen granulats.
ES538807A0 (es) Un procedimiento para la produccion de un complejo covalentemente unido de inhibidor de alfa-1-proteinasas con un polimero soluble en agua.
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
HUT52950A (en) Process for producing modified, long-acting gemfibrosyl compositions
ATE15142T1 (de) Antithrombotikum auf basis von polysacchariden, verfahren zur dessen herstellung und medizinale zusammensetzungen.
HK1030604A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
FR2647431B1 (fr) Procede et installation de production d'oxygene gazeux sous haute pression
ATE216576T1 (de) Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
ATE60713T1 (de) Pharmazeutische zusammensetzung aus guar-gummi und anderen antiacida zum schutz der oeso-gastro- duodenalen schleimhaut.
UA6028A1 (uk) Спосіб одержання біологічно активної композиції
ATE125707T1 (de) Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung.
ATE136465T1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE3274185D1 (en) Medicinal preparations for glycoside-hydrolase inhibitors
ATE72118T1 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
WO1990007260A3 (en) 2,3-methanoproline
DK43891A (da) Pentapeptid og fremgangsmaade til fremstilling deraf
JPS57159802A (en) Production of porous cellulose material
Backeus Mires in Oerebro county, central Sweden.
ES2043210T3 (es) Forma solida de medicamento con elevado contenido de verapamil.
ES2032304T3 (es) Producto aglomerado, su fabricacion y su utilizacion.

Legal Events

Date Code Title Description
EEFA Change of the company name
EELA Cancelled due to lapse of time